From: Clinical metagenomics assessments improve diagnosis and outcomes in community-acquired pneumonia
Characteristic | Control | mNGS | P-value |
---|---|---|---|
Total | 100 | 59 | NA |
Average age (year) | 74.2 (22–100) | 60.4 (21–90) | < 0.05 |
Sex | |||
Male | 73 (73%) | 41 (69.5%) | 0.71 |
Female | 27 (27%) | 18 (30.5%) | |
Concurrent conditions | 95 (95.0%) | 52 (88.1%) | 0.13 |
Cerebral infarction | 84 | 4 | < 0.05 |
Cardiovascular disease | 76 | 24 | < 0.05 |
Chronic lung diseases | 40 | 13 | 0.02 |
Diabetes mellitus | 25 | 18 | 0.47 |
Malignant solid tumor | 20 | 7 | 0.27 |
Renal insufficiency | 23 | 8 | 0.21 |
Immunosuppressive state | 14 | 11 | 0.5 |
Hepatic disease | 13 | 2 | 0.06 |
Hematologic malignancy | 6 | 13 | < 0.05 |